Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment

Abroad (travel likely)Recruiting

Conditions

Parkinson Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Study coordinator (Lucas Chang, BA) · lucas.m.chang@vumc.org · 615-421-3046
Contact: Principal Investigator (Sarah Bick, MD)

Study leads

Sarah Bick, MD
Principal Investigator
Vanderbilt University Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease

Parkinson Disease

Abroad (travel likely)RecruitingPHASE2

Davie, United States · Hialeah, United States

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

Parkinson Disease

Abroad (travel likely)Recruiting

Ann Arbor, United States

Longitudinal TSPO PET Imaging With [18F]DPA-714 in PPMI (PPMI DPA-714 PET Imaging)

Parkinson Disease

Abroad (travel likely)RecruitingEARLY_PHASE1

Birmingham, United States

Exercise Management in Parkinson's Disease

Parkinson Disease (PD)

Abroad (travel likely)Recruiting

Maltepe, Turkey (Türkiye)